Indigo Diabetes

ndigo Diabetes (Indigo) is a pioneer of continuous multi-metabolite monitoring and was founded by Danaë Delbeke and her team in 2016.

Today, Indigo is developing a next generation solution for continuous glucose monitoring (CGM) – called a continuous multi-metabolite monitoring system (CMM). It is designed to provide people living with diabetes access to information on their glucose and other metabolite levels at any given time, without requiring them to wear an external device on their body.

Indigo exploits ground-breaking nanophotonics technology, which was responsible for revolutionizing the Internet, to transform diabetes management.

Indigo is based in Ghent, Belgium.